B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial (Q45233045)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 April 2014

Language	Label	Description	Also known as
English	B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial	scientific article published on 29 April 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

phase I clinical trial

0 references

Bordetella pertussis

1 reference

based on heuristic

inferred from title

attenuated vaccine

1 reference

based on heuristic

inferred from title

pertussis vaccine

1 reference

based on heuristic

inferred from title

Nathalie Mielcarek

object named as

Nathalie Mielcarek

6

0 references

object named as

Sylvie Amu

2

0 references

Francesca Chiodi

object named as

Francesca Chiodi

5

0 references

object named as

Camille Locht

7

0 references

author name string

Maja Jahnmatz

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Margaretha Ljungman

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Lena Wehlin

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Rigmor Thorstensson

8

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

29 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

3350-3356

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

The seroepidemiology of Bordetella pertussis infection in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Pediatric disease burden and vaccination recommendations: understanding local differences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Infant pertussis: who was the source?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Bordatella pertussis respiratory infection in children Is associated with preferential activation of Type 1 T helper cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Human peripheral blood B-cell compartments: a crossroad in B-cell traffic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Intranasal vaccination with an adjuvanted Norwalk virus-like particle vaccine elicits antigen-specific B memory responses in human adult volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Priming with whole-cell versus acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

The challenges of vaccine responses in early life: selected examples

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.048

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.04.048

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45233045&oldid=2070762476"